ANALYSIS OF THE EFFICACY, SAFETY AND COST-EFFECTIVENESS OF DULOXETINE AND TRAZODONE TO TREAT NEUROPATHIC DIABETIC PAIN

被引：0
|
作者：
Silva, W. C. [1 ]
Crepalde, K. [1 ]
Guerra, A. A., Jr. [1 ]
Acurcio, F. A. [1 ]
机构：
[1] Univ Fed Minas Gerais, Sch Pharm, Dept Social Pharm, Post Grad Program, Belo Horizonte, MG, Brazil
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
107
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [21] Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
    Zilliox, Lindsay
    Russell, James W.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 7 - 17
  • [22] The safety of duloxetine in the long-term treatment of diabetic neuropathic pain
    Wernicke, J. F.
    Rosen, A. S.
    Pritchett, Y. L.
    Lee, T. C.
    Iyengar, S.
    Knopp, K.
    Ferdinand, S. J.
    Goldstein, D. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 222 - 222
  • [23] Treatment options for diabetic neuropathic foot ulcers: A cost-effectiveness analysis
    Kantor, J
    Margolis, DJ
    DERMATOLOGIC SURGERY, 2001, 27 (04) : 347 - 351
  • [24] Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain
    Ziegler, Dan
    Pritchett, Yili L.
    Wang, Fujun
    Desaiah, Durisala
    Robinson, Michael J.
    Hall, Jerry A.
    Chappell, Amy S.
    DIABETES CARE, 2007, 30 (03) : 664 - 669
  • [25] Duloxetine in the management of diabetic peripheral neuropathic pain
    Ormseth, Michelle J.
    Scholz, Beth A.
    Boomershine, Chad S.
    PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 343 - 356
  • [26] Duloxetine in treatment of diabetic neuropathic pain (DNP).
    Wernicke, J
    Lu, YL
    D'Souza, D
    Jones, M
    Waninger, A
    Tran, P
    PHARMACOTHERAPY, 2004, 24 (10): : 1422 - 1423
  • [27] DIABETIC NEUROPATHIC PAIN TREATMENT WITH DULOXETINE AND PREGABALIN
    Conti, G.
    Bresolin, N.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2009, 14 : 9 - 10
  • [28] Duloxetine in the treatment of diabetic peripheral neuropathic pain
    Goldstein, David J.
    FUTURE NEUROLOGY, 2006, 1 (06) : 700 - 711
  • [29] Pregabalin vs gabapentin in the treatment of neuropathic pain in Italy: A cost-effectiveness analysis
    Pradelli, L.
    Marchettini, P.
    Iannazzo, S.
    VALUE IN HEALTH, 2006, 9 (06) : A375 - A375
  • [30] Cost-effectiveness of duloxetine for knee OA subjects: the role of pain severity
    Sullivan, J. K.
    Huizinga, J.
    Edwards, R. R.
    Hunter, D. J.
    Neogi, T.
    Yelin, E.
    Katz, J. N.
    Losina, E.
    OSTEOARTHRITIS AND CARTILAGE, 2021, 29 (01) : 28 - 38
12345